Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...

Hims & Hers has been able to distinguish itself in a crowded field with its personalization strategy. Hims & Hers Health ...

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

DaVita HealthCare (DVA) ended the recent trading session at $137.84, demonstrating a +1.26% change from the preceding day's ...

Lennar (LEN) reported $8.38 billion in revenue for the quarter ended May 2025, representing a year-over-year decline of 4.4%.

SoFi is leveraging Galileo to diversify beyond its core consumer lending business, tapping into the broader digital banking ...

Healthcare giant Hims & Hers Health Inc (NYSE:HIMS) is one of the best performers on the New York Stock Exchange (NYSE) today, last seen up 9.2% at $36.18, continuing its volatile performance after ...

If you've been trying to reach your weight loss goals with no success, there are plenty of tools you can turn to for support.

GE HealthCare Technologies Inc. GEHC, on Thursday, announced the combination of its proprietary features and algorithms with ...

Detailed price information for Cisco Systems Inc (CSCO-Q) from The Globe and Mail including charting and trades.

As more CFOs step into the public spotlight by participating in events and conferences, the cost of misspeaking and the importance of leadership alignment on policy are increasing.